Everolimus Teva 5 mg Tablets
- Licence status
- Withdrawn: 17/03/2020
- Active substances
- Everolimus
- Dosage Form
- Tablet
- Licence number
- PA1986/034/002
- Licence holder
- Teva B.V.
Product documents
Licence information
- ATC code
- L01XE Protein kinase inhibitors, L01XE01 imatinib
- Route of supply
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Not marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 30/06/2017
Stay updated: document advice
The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie